TD Cowen Maintains Buy on Abbott Laboratories, Lowers Price Target to $118
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
TD Cowen analyst Joshua Jennings maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $135 to $118.
TD Cowen analyst Joshua Jennings maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $135 to $118.